Insmed Inc

NASDAQ:INSM 4:00:00 PM EDT

24.80

-1.38 (-5.27%)

6:11:58 PM EDT: $26.00 +1.20 (+4.84%)

Market Cap (Intraday)	3.68B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$78.51 Million
Adjusted EPS	-$1.24

See more estimates

10-Day MA	$26.66
50-Day MA	$27.47
200-Day MA	$25.70

See more pivots

Insmed Inc Stock, NASDAQ:INSM

700 US Highway 202/206, Building 10, Bridgewater, New Jersey 08807-3365

United States of America

Phone: +1.908.977.9900

Number of Employees: 912

http://www.insmed.com

Description

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.